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The relationships between mitochondrial respi-
ration, reactive oxygen species (ROS), and life
span are complex and remain controversial.
Inhibition of the target of rapamycin (TOR) sig-
naling pathway extends life span in several
model organisms. We show here that deletion
of the TOR1 gene extends chronological life
span in Saccharomyces cerevisiae, primarily
by increasing mitochondrial respiration via en-
hanced translation of mtDNA-encoded oxida-
tive phosphorylation complex subunits. Unlike
previously reported pathways regulating chro-
nological life span, we demonstrate that dele-
tion of TOR1 delays aging independently of the
antioxidant gene SOD2. Furthermore, wild-
type and tor1 null strains differ in life span only
when respiration competent and grown in nor-
moxia in the presence of glucose. We propose
that inhibition of TOR signaling causes dere-
pression of respiration during growth in glucose
and that the subsequent increase in mitochon-
drial oxygenconsumption limits intracellular ox-
ygen and ROS-mediated damage during glyco-
lytic growth, leading to lower cellular ROS and
extension of chronological life span.
INTRODUCTION
Mitochondrial respiration is the main source of reactive
oxygen species (ROS) production in most cells (Boveris
et al., 1972; Turrens, 1997). ROS, in turn, can damage cel-
lular macromolecules such as DNA and proteins and are
widely believed to contribute to functional decline and
increased mortality of cells and organisms over time
(Balaban et al., 2005; Finkel and Holbrook, 2000). How-
ever, while it is often incorrectly assumed that respiration
and ROS production are directly proportional, the biolog-
ical consequences of endogenous or exogenous changesCin respiration with respect to ROS production and life span
are complex and far from completely understood (Balaban
et al., 2005; Speakman et al., 2004). For example, life-
span extension has been attributed to both increases
and decreases in respiration (Barros et al., 2004; Bonawitz
et al., 2006b; Dillin et al., 2002; Feng et al., 2001; Lin et al.,
2002; Speakman et al., 2004), and ROS production by the
mitochondrial electron transport chain can be either in-
creased or decreased with pharmacological inhibitors of
respiration depending on the site and mode of action of
the drug (Kushnareva et al., 2002).
Mitochondria harbor their ownDNA (mtDNA), containing
a small but essential subset of genes encoding the oxida-
tive phosphorylation (OXPHOS) machinery. Transcription
of these mitochondrial genes is carried out by a dedicated
RNA polymerase and its associated transcription factors
(Bonawitz et al., 2006a). Though these proteins are distinct
from those responsible for transcription of nuclear genes,
they are themselves encoded in the nucleus and imported
into themitochondrion.More complex still is themitochon-
drial translation system. Again, this system is distinct from
that used in the expression of nuclear genes, but in this
case, theprotein components (ribosomal proteins, elonga-
tion factors, etc.) are encoded in the nucleus, whereas the
RNA components (rRNAs and tRNAs) are encoded by
mtDNA. Thus, mitochondrial ribosome biogenesis (and
OXPHOS complex assembly as well) requires precise co-
ordination of mitochondrial and nuclear gene expression,
the mechanisms of which are largely unknown. Interest-
ingly, a link exists between life span and mitochondrial
translation, as we have previously shown that yeast mu-
tants with globally reduced or imbalanced translation of
OXPHOS components exhibit increased ROS and abbre-
viated chronological life span (Bonawitz et al., 2006b).
The TOR (target of rapamycin) kinases are highly con-
served and regulate cell growth byphosphorylating a num-
ber of downstream targets in response to favorable nutri-
ent conditions and/or growth-factor signals (Harris and
Lawrence, 2003; Martin and Hall, 2005; Schmelzle and
Hall, 2000). Arguably the most substantial mechanism by
which TOR controls cell growth is via its influence on cyto-
plasmic translation. In the presence of favorable nutrients,
TOR not only greatly promotes the production of newell Metabolism 5, 265–277, April 2007 ª2007 Elsevier Inc. 265
Cell Metabolism
TOR Influences Life Span by Regulating Respirationribosomes but also increases translation from existing ri-
bosomes (Barbet et al., 1996; Schmelzle and Hall, 2000).
However, whether and how TOR regulates mitochondrial
translation has not been addressed.
The TOR pathway has warranted increased attention
from the aging-research community due to its apparently
conserved influence on life span in a number of organisms.
Decreased TOR signaling (using either RNAi or a hypomor-
phic TOR mutant) has been shown to extend life span in
the nematode Caenorhabditis elegans (Vellai et al., 2003).
Likewise, overexpression of a dominant-negative allele of
TOR or inhibitors of TOR (Tsc1 and Tsc2) extends life
span in Drosophila (Kapahi et al., 2004). Deletion of the
Saccharomyces cerevisiae TOR1 gene (encoding one of
two partially redundant TOR kinases in yeast) was shown
to increase replicative life span, the number of cell divi-
sions that a mother cell can support before senescence
(Kaeberlein et al., 2005). It should be pointed out that this
measure of cellular life span is distinguishable from chro-
nological life span, defined as the amount of time that
a nondividing cell can remain viable (Fabrizio and Longo,
2003). A recent high-throughput screen for gene deletions
that extend chronological life span yielded a number of
genes involved in nutrient sensing and influenced in part
by the TOR pathway (Powers et al., 2006). In addition, it
was shown that treatment of stationary-phase yeast
cultures with rapamycin, a specific inhibitor of TOR, also
extends chronological life span (Powers et al., 2006).
However, the TOR1 gene was not identified in this screen,
even though its deletion decreases TOR signaling.
The determination of the mechanism by which TOR sig-
naling limits life span is of critical importance. It has been
claimed that the chronological life-span extension result-
ing from TOR inhibition in yeast is dependent on upregula-
tion of stress-response genes by the Msn2/4 transcription
factors. However, it was shown that deletion of GLN3
(taken as a proxy for inhibition of TOR) dramatically ex-
tends life span even in an msn2/msn4 double mutant
(Powers et al., 2006). Thus, although the Msn2/4 factors
and their downstream targets are undoubtedly involved
in life-span regulation (Fabrizio and Longo, 2003; Fabrizio
et al., 2001), it appears that themajority of the life-span ex-
tension afforded by inhibition of TOR is Msn2/4 indepen-
dent. Furthermore, we have previously shown that respira-
tion and chronological life span are positively correlated in
yeast, with those strains that have the highest level of res-
piration showing the longest life span (Bonawitz et al.,
2006b). Therefore, we set out with the goal of determining
the mechanism of life-span extension afforded by de-
creased TOR signaling and whether alterations in mito-
chondrial respiration are involved.
RESULTS
Reduced TOR Signaling via Deletion of TOR1
Extends Chronological Life Span
and Increases Respiration
The S. cerevisiae genome encodes two partially redun-
dant TOR proteins called Tor1p and Tor2p that are inter-266 Cell Metabolism 5, 265–277, April 2007 ª2007 Elsevier Incchangeable as components of the nutrient-sensing TOR
complex I. However, Tor2p is also found in another com-
plex (TOR complex II), which is involved in cytoskeletal
remodeling. The functions of both TOR complexes are in-
dispensable; therefore, the TOR2 gene is essential, while
the TOR1 gene is not (Loewith et al., 2002). Although it
has been shown that deletion of TOR1 postpones replica-
tive aging (Kaeberlein et al., 2005), its effect on chronolog-
ical life span has not been reported. To address this,
we knocked out the TOR1 gene in S. cerevisiae strain
DBY2006, which we have used for aging studies previ-
ously (Bonawitz et al., 2006b). Deletion of TOR1 substan-
tially extended chronological life span, increasing median
survival almost 3-fold (wild-type 4.5 days, tor1 null 12
days) (Figure 1A). By 21 days in culture, the vast majority
of wild-type cells had died (>99.9%), whereas many tor1
null cells remained viable (Figure 1B). Deletion of TOR1
also extended the chronological life span of the relatively
short-lived strain BY4742 (Figure 1C), one of the two hap-
loid genetic backgrounds of the widely used Yeast Knock-
out Collection available from Open Biosystems. Analysis
of growth curves of all of the strains in Figure 1 demon-
strates that, while deletion of TOR1 resulted in a slightly
slower growth rate in log phase as predicted, the TOR1
and tor1 null strains both reached stationary phase at
day 1 postinoculation (see Experimental Procedures and
Figure S3 in the Supplemental Data available with this ar-
ticle online). We also compared the life span of tor1 null
cells to the life span of wild-type cells treatedwith rapamy-
cin, a specific inhibitor of the TOR pathway that has previ-
ously been reported to extend chronological life span
(Powers et al., 2006). Treatment of stationary phase cul-
tures of wild-type cells with rapamycin extended chrono-
logical life span compared to treatment with drug vehicle
(ethanol), albeit to a much lesser extent than deletion of
TOR1 (Figure 1D). Treatment of tor1 null cultures with ra-
pamycin actually decreased life span (Figure 1D). This ef-
fect was partially suppressed by expressing a rapamycin-
resistant allele of Tor2p (data not shown), suggesting that
optimal life-span extension is achieved in tor1 null strains
by decreasing overall TOR signaling while leaving Tor2p-
specific signaling intact.
In a previous study, we observed a striking correlation
between respiration at day 1 postinoculation and chrono-
logical life span in a number of strains, with those that
have the highest levels of respiration exhibiting the longest
life span (Bonawitz et al., 2006b). Therefore, we tested
whether this correlation held true in the tor1 null strain.
At day 1 postinoculation in glucose medium, tor1 null
strains in both the DBY2006 and BY4742 backgrounds
exhibited a reproducible 2-fold increase in oxygen
consumption in comparison to their respective wild-type
parent strains (Figure 1E). Interestingly, the short-lived
BY4742 strain showed substantially lower rates of
oxygen consumption than DBY2006, with both wild-type
and tor1 null strains of BY4742 exhibiting only 30%
of the oxygen consumption of the corresponding
DBY2006 strains (Figure 1E). This observation extends
the correlation between respiration and life span noted.
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TOR Influences Life Span by Regulating RespirationFigure 1. Deletion of TOR1 Extends Chronological Life Span and Increases Respiration in Two Different Yeast Strains
(A) Chronological life-span curves (i.e., % viability versus days in stationary phase) of wild-type (closed circles) and tor1 null cells (open circles) over
two weeks, as assessed by staining with trypan blue. The curves shown were generated by compiling survival measurements from 11 different
samples performed in 5 independent experiments. For clarity, we have marked the approximate median survival point of each curve with a dotted
line. In this and all other figures, error bars represent standard deviation unless otherwise noted.
(B) Serial 10-fold dilutions of stationary-phase cultures plated onto rich medium (YPD) at day 1 (upper panel) and day 21 (lower panel).
(C) Chronological life-span measurements of wild-type and tor1 null derivatives of the short-lived strain BY4742 plotted as described in (A). *p < 0.05;
**p < 0.005; ***p < 0.0005.
(D) Chronological life-span curves of wild-type and tor1 null cells treated with 50 nM rapamycin or drug vehicle (ethanol). Survival was monitored by
trypan blue staining.
(E) Mitochondrial oxygen consumption of wild-type and tor1 null derivatives of strains DBY2006 (left) and BY4742 (right) at day 1 postinoculation in SD
medium.Cell Metabolism 5, 265–277, April 2007 ª2007 Elsevier Inc. 267
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TOR Influences Life Span by Regulating RespirationFigure 2. Deletion of TOR1 Fails to Extend Life Span in Petite Strains that Are Unable to Respire
Life-span curves of mitochondrial petite derivatives of wild-type and tor1 null strains due to inactivated mtDNA (A) or deletion of the COQ5 gene
(B) plotted as described in Figure 1, except that time is reported in hours.above (Bonawitz et al., 2006b). Treatment of wild-type
cells with rapamycin likewise led to increased respiration,
though to a lesser degree than deletion of TOR1 (Fig-
ure S1). In contrast, treatment of tor1 null cells with rapa-
mycin effected a substantial decrease in respiration
(Figure S1). The reasons for this decrease are unclear;
however, coupledwith the observation that rapamycin de-
creases life span in tor1 null cells, it appears likely that ex-
cessive inhibition of TOR signaling leads to deleterious
consequences for both the maintenance of respiration
and life span.
Respiration Is Required for Life-Span Extension
in tor1 Null Strains
Based on our extensive observations of a correlation
between oxygen consumption and life span as well as
previous suggestions that high levels of respiration corre-
late with long life (Barros et al., 2004; Lin et al., 2002;
Speakman et al., 2004), we hypothesized that the in-
creased respiration exhibited by tor1 null cells was directly
responsible for their enhanced longevity. To test this, we
generated respiration-defective (petite) isolates of our
wild-type and tor1 null strains using a standard ethidium
bromide treatment that induces deletion and/or loss of
mtDNA. Since mtDNA encodes essential OXPHOS com-
ponents, these strains are unable to respire. We found
that the life span of both wild-type and tor1 null petite de-
rivatives of strain DBY2006 was similar to the short-lived
strain BY4742 (Figure 1C) and much briefer than their
respiration-competent parent strains, consistent with an
important role for mitochondrial respiration in the mainte-268 Cell Metabolism 5, 265–277, April 2007 ª2007 Elsevier Inc.nance of life span (Figure 2A). However, in contrast to
the life-span extension seen in respiration-competent
BY4742 cells, deletion of TOR1 in petite strains extended
life span only very minimally, and only at early time points.
To confirm that this was due to the elimination of respira-
tion and not other unexpected consequences resulting
from the inactivity or elimination of mtDNA, we also mea-
sured the life span of wild-type and tor1 null strains that
are petite due to deletion of the nuclear COQ5 gene.
Coq5p is essential for the synthesis of the mitochondrial
electron carrier coenzyme Q, and although coq5 mutants
are unable to respire, mtDNA is maintained. The life span
of the coq5 petite mutant mirrored that of the mitochon-
drial petites described above (Figure 2B; see also growth
curves in Figure S3). Therefore, we conclude that mito-
chondrial respiration is required for themajority of the abil-
ity of TOR1 deletion to extend life span in yeast.
Differences in Both Respiration and Life Span
between Wild-Type and tor1 Null Strains
Are Glucose Dependent
The main function of the TOR pathway is nutrient sensing,
the coordination of cellular metabolism with nutrient avail-
ability. Furthermore, TOR has been shown to be involved
in modulating the expression of at least some genes in
response to glucose (Tomas-Cobos et al., 2005). Since re-
spiratory activity in facultative anaerobes like S. cerevisiae
is contingent on the availability of glucose, we tested
whether the tor1 null phenotypes we observed were
glucose dependent. We found that oxygen consump-
tion levels of wild-type and tor1 null cells at day 1
Cell Metabolism
TOR Influences Life Span by Regulating RespirationFigure 3. The Increased Respiration and Life-Span Phenotypes of tor1 Null Cells Are Glucose Dependent, and a Known Glucose-
Repression Mutant, reg1, Phenocopies tor1 Null
(A) Mitochondrial oxygen consumption of wild-type and tor1 null cultures growing in glycerol medium before (left) and 4 hr after (right) addition of
glucose (to 2%). Error bars in all panels of this figure represent the standard deviation of three replicates.
(B) Chronological life-span curves of wild-type and tor1 null cells grown in glycerol medium.
(C) As in (B), except that glucose was added (to 2%) at day 1.
(D) Mitochondrial oxygen consumption of wild-type and tor1 null cells, graphed as a function of culture density (OD600). The points shown are the
combination of three independent experiments, and each represents an individual oxygen consumption reading.
(E) Oxygen consumption of reg1 null cells and their isogenic wild-type control (BY4741) at day 1.
(F) Chronological life span measurements of the cultures described in (E) over three days in stationary phase.postinoculation in growth medium containing glycerol as
a sole carbon source (SG medium) were indistinguishable
from one another (Figure 3A, left) and, as expected, were
significantly higher than those exhibited by day 1 glucose
cultures (compare Figure 3A with Figure 1E). Upon addi-
tion of glucose to glycerol cultures, a difference in the ox-
ygen consumption of wild-type and tor1 null cells was ob-
served within 4 hr (Figure 3A, right). Consistent with the
correlation between respiration and life span described
above, the life spans of wild-type and tor1 null cultures
grown in glycerol were also indistinguishable, and both
strains showed longer life span in glycerol medium than
in glucose (compare Figure 3B with Figure 1A). Addition
of glucose to glycerol cultures at day 1 postinoculationCwas sufficient to restore a difference in the life span of
wild-type versus tor1 null cultures by causing a greater de-
crease in life span in wild-type than in tor1 null cells (Fig-
ure 3C). We observed similar results for cells grown in
media containing raffinose as the sole carbon source (data
not shown). When oxygen consumption measurements
were taken throughout a typical growth curve in glucose-
containing medium, it became clear that as wild-type cul-
tures approach saturation (where glucose is exhausted),
their oxygen consumption increases, whereas respiration
in tor1 cultures remains high at all stages of growth
(Figure 3D). After extended amounts of time in saturation
(2 days and beyond), oxygen consumption of wild-type
and tor1 null cultures was identical when corrected forell Metabolism 5, 265–277, April 2007 ª2007 Elsevier Inc. 269
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that the inhibitory function of the TOR pathway on res-
piration and life span is only active in the presence of
glucose.
Increased Respiration Due to Faulty Glucose
Repression in reg1 Null Strains Mimics the
Extension of Life Span by TOR1 Deletion
Having shown that eliminating respiration severely attenu-
ates the effect of TOR signaling on life span and that in-
creasing respiration via growth in glycerol extends life
span, we sought to test whether another genetic manipu-
lation reported to increase respiration would influence life
span in a manner similar to TOR inhibition. As described
above, wild-type yeast cells prefer glycolysis over respira-
tion and repress respiration in the presence of glucose.
We therefore tested a known glucose-repression-defec-
tivemutant, reg1D (Matsumoto et al., 1983), for respiration
and stationary-phase survival phenotypes. Like deletion
of TOR1, deletion of REG1 led to substantially higher res-
piration levels at day 1, increasing oxygen consumption
more than 2-fold compared to the isogenic parent strain
(Figure 3E). As predicted, the higher level of oxygen con-
sumption seen in reg1 null cells correlated with increased
stationary-phase survival compared to control cells
(Figure 3F), thus adding additional weight to our conclu-
sion that increased respiration is responsible for life-
span extension in tor1 null cells.
Life-Span Extension by TOR1 Deletion Is
Independent of SOD2 despite the Upregulation
of Sod2p Abundance
Some of the life-span extension resulting from TOR inhibi-
tion has been previously attributed to increased stress re-
sistance (Powers et al., 2006). Also, it has been shown that
the life-span extension resulting from inhibition of the well-
characterized Sch9p pathway is completely eliminated by
deletion of SOD2, the gene encoding the mitochondrial-
matrix-localized manganese-dependent superoxide dis-
mutase (Fabrizio et al., 2003). We therefore investigated
the potential role of SOD2 in the phenotype of tor1 null
cells. We first measured steady-state abundance of
Sod2p by western blot analysis at both day 1 and day 2
postinoculation in wild-type and tor1 null cells. Surpris-
ingly, we found that Sod2p levels were identical in
wild-type and tor1 null cells at day 1 and were increased
in tor1 null cells only at day 2 of stationary phase
(Figure 4A). (One might predict that if TOR signaling influ-
ences SOD2 expression, then deletion of TOR1 would
have the greatest effect during growth, when TOR signal-
ing is most active.) Consistent with this observation, we
found that ROS abundance in wild-type and tor1 null cells
was identical at day 1 postinoculation but diverged at day
2, with wild-type cells, but not tor1 null cells, exhibiting sig-
nificantly more ROS at day 2 than at day 1 (Figure 4B). We
alsomeasured resistance of wild-type and tor1 null cells at
day 1 and day 2 to hydrogen peroxide, an inducer of oxi-
dative stress. We found that at day 1, tor1 null cells were
more sensitive to hydrogen peroxide than wild-type cells270 Cell Metabolism 5, 265–277, April 2007 ª2007 Elsevier Incwere, but, interestingly, the situation was reversed at
day 2 (Figure 4C). We next deleted the SOD2 gene in
wild-type and tor1 null cells to test whether life-span ex-
tension via inhibition of TOR signaling was dependent on
the presence of Sod2p. Neither deletion of SOD2 nor its
replacement with a plasmid-borne copy had any measur-
able impact on the ability of TOR1 deletion to extend chro-
nological life span (Figure 4D). Taken together, these data
indicate that, in contrast to previously characterized path-
ways involved in the regulation of chronological life span,
the expression of superoxide dismutase is unlikely to
contribute substantially to the increased chronological
life span resulting from TOR1 deletion. Nonetheless, our
results do implicate TOR signaling in the regulation of
expression and/or stability of Sod2p.
Limiting Culture Aeration Early in Growth Mimics
TOR1 Deletion
One potential consequence of the increased respiration
observed in the tor1 null strain is that intramitochondrial
oxygen levels could be lower than in the wild-type strain,
a situation that is unfavorable for ROS production (Vinog-
radov and Grivennikova, 2005). We reasoned that if this is
the case, then limiting oxygen availability to wild-type cells
should be beneficial for life span. We grew wild-type and
tor1 null cultures under hypoxic conditions by limiting cul-
ture aeration and measured viability compared to normal
growth conditions. Wild-type cultures grown for 4 or 5
days in hypoxic conditions contained significantly more
viable cells than cultures grown normally. In contrast,
hypoxia had no effect on the viability of tor1 null cultures
(Figure S2A).
As described above, we observed a difference between
the respiratory rate of wild-type and tor1 null cells only
during the initial stages of growth (i.e., by day 2, both
strains showed similar levels of respiration). If this differ-
ence in respiration is responsible for the extended life
span in tor1 null cells, and if limiting oxygen mimics this ef-
fect, then we reasoned that it should be possible to effect
a substantial increase in viability in wild-type cultures by
limiting aeration only during the first 2 days in culture.
Remarkably, we found that growing wild-type cells for
just 2 or 4 days in hypoxia and then switching to normoxia
rendered their viability indistinguishable from tor1 null
cells at day 21 (compare Figure S2B with Figure 1B). We
conclude that an oxygen-dependent process that occurs
early in the course of normally growing wild-type cultures
is responsible for their rapid loss of viability later in station-
ary phase and that tor1 null cells are resistant to this
process.
TOR Regulates Mitochondrial Translation
Given the known role of the TOR pathway in regulating
cytoplasmic translation of nucleus-encoded genes, we
tested the hypothesis that the increase in mitochondrial
respiration that we observed in tor1 null strains was medi-
ated through an effect onmitochondrial translation. To ad-
dress this, we first quantified mitochondrial translation
rates using a standard in vivo labeling approach that we.
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TOR Influences Life Span by Regulating RespirationFigure 4. Sod2p Is Upregulated Specifically in Stationary Phase in tor1 Null Cells and Contributes to Stress Resistance, but Not to
Life-Span Extension
(A) Western blot analysis of Sod2p levels in wild-type and tor1 null cells at day 1 and day 2 of stationary phase. Shown at top is a pair of representative
samples, and shown below is quantification of Sod2p relative to actin from three biological replicates.
(B) ROS levels of wild-type and tor1 null cells at day 1 postinoculation, measured with the ROS-sensitive fluorescent dye dihydroethidium (DHE) and
flow cytometry. The y axis shows the number of cells measured at a given point on the x axis, which is a logarithmic scale of arbitrary fluorescence
units. The black line represents the fluorescence profile of the wild-type strain, and the filled gray curve represents that of the tor1 null strain.
(C) Serial 10-fold dilutions of wild-type and tor1 null cells treated with the indicated levels of hydrogen peroxide (H2O2) at either day 1 or day 2 of
stationary phase.
(D) Life-span curves of sod2 mutants (closed squares), tor1 sod2 double mutants (closed circles), and tor1 sod2 double mutants transformed with
a plasmid bearing wild-type SOD2 (open circles) compared to appropriate empty-vector control strains.have used previously to measure mitochondrial protein
synthesis (Rodeheffer and Shadel, 2003). Cultures of
wild-type and tor1 null cells at day 1 postinoculation
were treated with emetine (to inhibit cytoplasmic transla-
tion) and then incubated with 35S-labeled methionine to
measure incorporation into mtDNA-encoded proteins. In
this assay, tor1 null cells incorporated3-fold more radio-
label than wild-type cells, indicating a greater rate of mito-
chondrial translation (Figure 5A).
Consistent with the results described above,we foundby
western blotting that the steady-state levels of the mito-
chondrially encoded cytochrome c oxidase (complex IV)
subunits Cox2p and Cox3p were 2-fold and 3.5-fold
greater, respectively, in tor1 null strains (Figure 5B). Finally,
we measured the resistance of wild-type and tor1 null cells
to chloramphenicol, an inhibitor of mitochondrial ribo-Csomes, hypothesizing that if tor1 null cells do indeed have
greater rates of mitochondrial translation due to increased
mitochondrial ribosomebiogenesis, theywould then exhibit
resistance to this drug. Wild-type and tor1 null cells were
grown in glycerol medium (which requires respiration and
therefore mitochondrial gene expression) containing either
0.25 mg/ml chloramphenicol or drug vehicle. Chloram-
phenicol treatment of wild-type cells led to an 65% de-
crease in growth rate compared to untreated cells, whereas
treatment of tor1 null cells inhibited growth by only 40%
(Figure 5C). Taken together, these results indicate that the
TOR pathway normally serves to inhibit respiration by re-
pression of synthesis of mtDNA-encoded proteins. Con-
versely, deletion of the TOR1 gene increases respiration
via the derepression of these genes and perhaps also by
increasing mitochondrial ribosome biogenesis.ell Metabolism 5, 265–277, April 2007 ª2007 Elsevier Inc. 271
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TOR Influences Life Span by Regulating RespirationFigure 5. tor1Null Cells Exhibit Increased
Translation and Steady-State Levels of
Mitochondrially Encoded Proteins
(A) Specific incorporation of 35S-labeled methi-
onine into mtDNA-encoded OXPHOS subunits
in wild-type and tor1 null strains (DBY2006 ge-
netic background), plotted in millions of counts
per minute (cpm 3 106).
(B) Western blot analysis of twomitochondrially
encoded subunits of cytochrome c oxidase,
Cox2p and Cox3p, at day 1 postinoculation.
The left panel shows levels of actin (a loading
control), Cox2p, and Cox3p in two representa-
tive samples, and the right panel shows quanti-
fication of Cox2p and Cox3p in three indepen-
dent samples. For quantification, the ratio of
actin:Cox2p or actin:Cox3p was determined
for all samples and then normalized to the aver-
age wild-type ratio.
(C) Chloramphenicol resistance of wild-type
and tor1 null strains. Shown is the ratio for
both wild-type and tor1 null cells of growth in
glycerol medium containing 0.25 mg/ml chlor-
amphenicol to growth in glycerol without chlor-
amphenicol.DISCUSSION
Due to its involvement in many critical biological pro-
cesses, interest in the TOR signaling pathway has grown
at an astounding rate since its discovery in the early
1990s. Recently it has become clear that TOR plays an im-
portant role in the regulation of life span in bothmetazoans
and yeast, though the precise mechanisms by which this
regulation occurs has been unclear. The main conclusion
we draw from our experimental results is that inhibition of
TOR signaling extends life span in yeast by increasing
respiration via enhanced mitochondrial gene expression.
First, deletion of the TOR1 gene increases respiration
(Figure 1E) and extends life span (Figure 1A) in two differ-
ent yeast strains, DBY2006 and BY4742. Both wild-type
and tor1 null strains of BY4742 show lower respiration
than their DBY2006 counterparts, as well as shorter life
span. Treatment of wild-type cells with rapamycin, which
has previously been reported to extend life span, also in-
creases respiration (Figure S1), though to a lesser degree
than deletion of TOR1. Growth in glycerol medium renders
both respiration and life span indistinguishable between
wild-type and tor1 null cells, increasing both substantially
in comparison to growth in glucose (Figures 3A–3C). Fur-
thermore, another genetic manipulation that results in272 Cell Metabolism 5, 265–277, April 2007 ª2007 Elsevier Inc.higher rates of respiration (REG1 deletion) similarly ex-
tends life span (Figures 3E and 3F). And finally, elimination
of respiration in strains lacking functional mtDNA
(Figure 2A) or via deletion ofCOQ5 (Figure 2B) (to eliminate
production of the essential electron carrier coenzyme Q)
almost completely abolishes life-span extension in a tor1
null strain, showing that respiration is responsible for the
vast majority of the influence of the TOR pathway on life
span. It is possible that there is a slight (i.e., several
hour) extension of life span in petite tor1 null strains at
early time points (Figures 2A and 2B). Though it is arguable
whether this effect is of biological significance, it is possi-
ble that eliminating respiration unmasks a slight difference
between wild-type and tor1 null cells due to influences on
stress resistance.
As mentioned above, the increase in both respiration
and life span in tor1 null cells is dependent on the pres-
ence of glucose. Thus, in wild-type cells, the TOR pathway
normally plays a role in glucose-dependent inhibition of
respiration, extending further the extensive list of cellular
functions influenced by TOR.We do not yet know whether
TOR is involved in the well-characterized process of ca-
nonical glucose repression or represents a previously un-
known input to the regulation of respiration. However, we
have presented evidence that the mechanism by which
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ence of glucose is via upregulation of mitochondrial
gene expression (Figure 5). Although inhibition of the
TOR pathway leads to decreased global (cytoplasmic)
translation (Barbet et al., 1996; Gingras et al., 2001;
Schmelzle and Hall, 2000), we have shown that tor1 null
cells exhibit a higher rate of mitochondrial translation
(Figure 5A) and steady-state abundance of several mito-
chondrially encoded OXPHOS components (Figure 5B)
and are resistant to an inhibitor of mitochondrial ribo-
somes (Figure 5C). We therefore conclude that TOR in-
fluences the reciprocal allocation of resources between
cytoplasmic and mitochondrial translation. Consistent
with our results showing a direct effect of TOR on mito-
chondrial translation is the report by Shamji et al. (2000)
showing that treatment of yeast with rapamycin in-
creases the expression of a number of genes involved
in the TCA cycle, mitochondrial ribosome biogenesis,
and assembly of the OXPHOS complexes. Thus, the
TOR signaling pathway apparently has a global and piv-
otal role in regulating mitochondrial gene expression and
oxidative metabolism.
Stress-resistance pathways, and specifically the Sod2p
protein, have been shown to be very important players in
the maintenance of chronological life span (Fabrizio and
Longo, 2003; Fabrizio et al., 2001). Deletion of the SOD2
gene, for example, completely eliminates the life-span ex-
tension observed in a sch9 null strain (Fabrizio et al., 2003).
However, it is clear from our results that inhibition of TOR
is acting in another fashion. We found that deletion of
SOD2 had no effect on the ability of TOR1 deletion to ex-
tend life span (Figure 4D). Interestingly, although conven-
tional wisdom states that inhibition of TOR signaling
should lead to generally increased stress resistance, sev-
eral studies have shown that deletion of TOR1 in S. cere-
visiae actually sensitizes cells to a number of different
stresses, including heat, salt, and cell-wall stresses
(Crespo et al., 2001; Reinke et al., 2004). Similarly, tor1
null strains of Schizosaccharomyces pombe exhibit in-
creased sensitivity to heat, oxidative, pH, and osmotic
stresses (Kawai et al., 2001; Weisman and Choder,
2001). Consistent with these results, we found that tor1
null strains are sensitive to hydrogen peroxide at day 1
(Figure 4C). Surprisingly, we found that deletion of TOR1
influenced SOD2 levels only in later stationary phase,
causing its upregulation (and increased resistance to oxi-
dative stress) only at day 2 postinoculation (Figures 4A
and 4C). Based on our oxygen consumption data (where
we see effects only at day 1), as well as the generally ac-
cepted fact that TOR signaling is largely inactivated during
stationary phase/starvation, we had predicted that any ef-
fect of TOR inhibition on SOD2 would be manifest sooner
rather than later. These data lead us to speculate the exis-
tence of alternative TOR signaling that occurs only during
stationary phase. Indeed, this hypothesis is consistent
with our observation that the treatment of tor1 null cells
with rapamycin actually causes them to die (Figure 1D), in-
dicating that some level of TOR signaling in stationary
phase is essential to maintain viability.CAlthough Sod2p is not required for life-span extension in
tor1 null cells (Figure 4D), it is still quite probable that ROS
are involved in the life-span extension by TOR given that
the presence of oxygen (the substrate for ROS) is required
to observe a difference in life span between wild-type and
tor1 null strains (Figure S2). We previously showed that
inhibition of respiration via imbalanced production of
OXPHOS components leads first to ROS production and
subsequently to the complete inactivation of respiration
(Bonawitz et al., 2006b). We interpreted these data as
evidence for the often cited ‘‘vicious cycle’’ of oxidative
damage, wherein oxidatively damaged components of
the OXPHOSmachinery result in higher levels of ROS pro-
duction, which then causemore damage, etc. Conversely,
the increased respiration in tor1 null cells could result in
decreased production of ROS by the mitochondrial elec-
tron transport chain. Although we do not see a difference
in the amount of ROS at day 1 postinoculation, it should be
pointed out that our ROS data are measurements of
steady-state abundance. Thus, if hydrogen peroxide sen-
sitivity in a tor1 null strain is taken as an indication that its
antioxidant capacity is lower than that of wild-type, then
the observation of equivalent ROS steady-state levels in
the two strains implies that tor1 null cells produce less
ROS. Consistent with this hypothesis, we have observed
fewer numbers of mitochondrial petites in tor1 null cul-
tures (data not shown), suggesting lower amounts of dam-
age to mitochondrial DNA (Shadel, 1999). Alternatively, it
is possible that there is a relevant difference in ROS levels
between wild-type and tor1 null cells but that it was unde-
tectable by the methods used.
Although it is often casually stated that respiratory rate
should correlate with ROS production, there is mounting
evidence from a number of groups suggesting that it is
not the absolute number of electrons flowing through the
electron transport chain but rather the state of the chain
that determines the rate of ROS production. It has been
shown, for example, that high membrane potential favors
the formation of ROS (Korshunov et al., 1997; Papa and
Skulachev, 1997), as does high oxygen concentration
(Vinogradov and Grivennikova, 2005), in both cases at
levels found in vivo. Also, when isolated mitochondria
are shifted from state IV (ADP-limited) to state III (sub-
strate-limited) respiration, they show a substantial in-
crease in the amount of oxygen they consume without
a concomitant increase in ROS (Barja, 1999). The emerg-
ing model posits, in fact, that conditions of rest (low met-
abolic rate) can actually favor ROS production (Papa and
Skulachev, 1997; Wallace, 2005). In the presence of ex-
cess oxidizable substrates (i.e., calories), respiration is
limited only by the availability of ADP and approaches
state IV. Since ADP is required for complex V (ATP syn-
thase) to allow protons to flow back into the matrix, mem-
brane potential climbs, electron transport stalls as all sites
become reduced, and the dwell time of radical-generating
intermediates increases. These radical intermediates then
react with the growing concentration of oxygen not being
utilized by the stalled respiratory chain. Consistent with
this model, caloric restriction, which extends life span inell Metabolism 5, 265–277, April 2007 ª2007 Elsevier Inc. 273
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TOR Influences Life Span by Regulating RespirationFigure 6. A SpeculativeModel Describing the Influence of TORSignaling onChronological Life Span through Effects onMitochon-
drial Translation, Respiration, and ROS Production
Based on our results, TOR normally negatively influences mitochondrial gene expression by repressing mitochondrial translation and/or ribosome
biogenesis (depicted as the number of mitochondrial ribosomes) during growth in glucose (A). While likely optimal for growth on glucose via glycolysis
and subsequent fermentation, this has a deleterious effect on life span by promoting ROS production. We propose that this occurs because a less
active electron transport chain (consisting of the OXPHOS complexes shown embedded in the inner mitochondrial membrane) first accumulates re-
duced and reactive redox components (shown as OXPHOS components with explosions) that can more readily transfer electrons (e) to oxygen (O2;
gray double circles) prior to complex IV to generate ROS (O2molecules with explosions) instead of water (H2O; gray circles with black circles attached)
and additionally allows more oxygen, the substrate for ROS, to accumulate in mitochondria. In other words, the electron transport chain becomes
reduced andmitochondrial oxygen concentration rises, favoring ROS production and initiating the vicious cycle of mitochondrial and cellular damage
that further reduces mitochondrial respiration and limits life span. In tor1 null cells (B), mitochondrial translation and/or ribosome biogenesis is dere-
pressed, leading to a greater steady-state level of OXPHOS complexes in the inner mitochondrial membrane. This scenario is proposed to facilitate
oxidization of the mitochondrial electron transport chain and keep intramitochondrial oxygen levels low, limiting ROS production and accumulation
and delaying the onset of the life-span-limiting vicious cycle.mice (Masoro, 2003), has been shown to increase respira-
tory rate (Lambert and Merry, 2004). Thus, nutrient sens-
ing, caloric restriction, mitochondrial respiration, and life
span all appear to be linked. Furthermore, we previously
showed that a partial block in the respiratory chain due
to imbalanced production of mitochondrially encoded
components generates ROS and shortens life span in
yeast (Bonawitz et al., 2006b), and Barros et al. (2004)
showed the converse, that ROS production could be in-
hibited by activating respiration (Barros et al., 2004).
Taken together with the results of this study, it is tempting
to speculate that the measurable mitochondrial respira-
tion occurring in yeast growing glycolytically is similarly
acting as a sort of ‘‘release valve,’’ oxidizing the electron
transport chain and reducing unwanted oxygen as
a means to limit ROS production, and that this activity is
increased in strains with an inhibited TOR pathway.
We propose the following model to describe all of our
results taken together (Figure 6). In wild-type cells in the
presence of glucose, TOR inhibits mitochondrial transla-274 Cell Metabolism 5, 265–277, April 2007 ª2007 Elsevier Inc.tion and/or ribosome biogenesis. This inhibition allows
cells to grow more quickly, but as a result of the low num-
ber or activity of respiratory complexes, oxygen concen-
tration is high and the transit time of electrons through
the chain is protracted, reducing the chain and favoring
the formation of ROS. These ROS can damage cellular
components including mtDNA and OXPHOS compo-
nents, setting into motion the vicious cycle of oxidative
stress that eventually results in death. However, the evolu-
tionary benefits for a facultative anaerobe of quick growth
and utilization of resources while they are available out-
weigh the cost of short life span; thus, inhibition of respira-
tion by TOR is favored by evolution and is retained.
Disruption of TOR signaling, via deletion of TOR1, dere-
presses respiration by increasing mitochondrial transla-
tion and generates less ROS as a result of the presence
of more OXPHOS complexes. This postpones the initia-
tion of the vicious cycle and extends life span but comes
at the cost of slowing growth. Thus, we propose that oxi-
dative stress experienced during the initial stages of
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TOR Influences Life Span by Regulating Respirationculture can manifest itself much later by damaging cellular
components, particularly in stationary phase, where the
ability to make new OXPHOS complexes and other mito-
chondrial components is likely compromised due to the
downregulation of cytoplasmic translation. Supporting
this model are our results showing that limiting culture aer-
ation (i.e., oxygen concentration) mimics the effects of re-
duced TOR signaling, even if administered only during the
initial stages of culture growth.
Although our results apparently contradict a recent pub-
lication showing that TOR activates respiration in human
cells (Schieke et al., 2006), we feel that this can be simply
explained by differences in the nature of glucose metabo-
lism between humans and yeast, with the former favoring
aerobic and the latter anaerobic metabolism. That is, both
sets of results are consistent with the idea that the pro-
growth TOR pathway has a hand in increasing glucose
metabolism, but in humans, this glucose is ultimately fed
into mitochondrial respiration, whereas in yeast, respira-
tion is inhibited and anaerobic fermentation predomi-
nates. A discrepancy also exists between our model and
that of Powers et al. (2006), who claim that life-span exten-
sion by TOR inhibition is due in part to Msn2/4-mediated
stress resistance. However, we feel that this conclusion
does not follow from their results and furthermore suggest
that deletion of one downstream target of a signaling path-
way as intricate as TOR cannot be expected to recapitu-
late the phenotype of inhibiting the entire pathway. Finally,
although it has been shown that RNAi or mutation of mito-
chondrial OXPHOS components extends life span in
worms (Dillin et al., 2002; Feng et al., 2001; Lee et al.,
2003), providing important insight into aging in meta-
zoans, there are indications that this is not simply due to
the ‘‘less respiration, less ROS’’ explanation. Dillin et al.
(2002), for example, showed that inhibition of respiration
only extends life span if imposed during development,
suggesting some sort of ‘‘metabolic reprogramming’’; al-
ternatively, it has been proposed that the effects of respi-
ration inhibition inC. elegans could be due to the use of an
alternate anaerobic mode of respiration utilizing fumarate
as an alternative electron sink and producing fewer ROS
(Rea and Johnson, 2003).
In summary, we have revealed important connections
among the TOR pathway, mitochondrial respiration, and
life span that provide insight into how these likely syner-
gize to influence aging and longevity. Of particular note
is our discovery that mitochondrial translation and respira-
tion are downstream targets of TOR, indicating that the
regulation of mitochondrial metabolism is critical for bal-
ancing cell growth and life span in response to nutrients.
It is already documented that there is crosstalk between
the TOR pathway and the retrograde pathway (Butow
and Avadhani, 2004; Crespo et al., 2002), which relays sig-
nals from the mitochondria to the nucleus. This, coupled
with our results showing that TOR is signaling to mito-
chondria, implies the existence of a homeostatic regula-
tory circuit operating in cells whereby mitochondrial respi-
ratory capacity and ROS production are both sensed and
controlled by the TOR pathway. Determining preciselyChow this circuit operates and influences aging and life
span is fertile ground for future investigation.
EXPERIMENTAL PROCEDURES
Yeast Strains and Media
Media and techniques for culturing and genetic manipulation of yeast
were used as described in Sherman (1991). Synthetic dextrose (SD),
synthetic glycerol (SG), rich dextrose (YPD), and rich glycerol (YPG)
media were used as indicated. Unless otherwise indicated in the
text, experiments were carried out with strain DBY2006 (MATa his3-
D200 leu2-3,-112 ura3-52 trp1-D1 ade2-1) or a derivative. The tor1
null derivative of DBY2006 was generated by transformation with
a PCR-amplified tor1::kanMx4 deletion cassette from the tor1 null
strain of the Yeast Knockout Collection available from Open Biosys-
tems. The reg1 null strain and its isogenic wild-type control were deriv-
atives of BY4742 (MATa his3-D1 leu2D0 lys2-D0 ura3-D0), obtained
directly from the Yeast Knockout Collection. The sod2 and coq5 null
strains of DBY2006 and DBY2006 tor1 null were generated by PCR
amplification and transformation with TRP1 and HIS3 knockout cas-
settes, respectively. Trp+ and His+ transformants were screened by
PCR to confirm correct insertion of the knockout cassettes, and the
coq5 null strain was further verified by its inability to grow on YPG
medium. The SOD2 overexpression plasmid used was described pre-
viously (Bonawitz et al., 2006b). Mitochondrial petite strains were
generated using a standard ethidium bromide method based on that
described in Slonimski et al. (1968). Inability to respire was confirmed
by lack of growth on YPG medium.
Chronological Life Span
Our method for the determination of chronological life span has been
described previously (Bonawitz et al., 2006b). Briefly, cultures were in-
oculated to anOD600 of0.05 in 50ml total volume in 125ml flasks and
incubated at 30C in an orbital shaker moving at 200 rpm. Viability was
assayed either by staining a 100 ml sample of the culture with 100 ml of
trypan blue (0.4 mg/ml), incubating at 30C for 5 min, and counting
clear versus blue cells or by plating serial dilutions onto YPD plates,
as indicated. Growth of TOR1 and tor1 null cells was measured to en-
sure that the absence of the TOR1 gene did not significantly change
the amount of time taken to grow from inoculation to stationary phase
(Figure S3). This held true for all strains except coq5 null and coq5 tor1
null. In this case, coq5 tor1 null cells took at least 6 hr longer than coq5
null cells to reach stationary phase. The viability curve shown in
Figure 2B takes this 6 hr lag into account. For the life-span experiments
shown in Figure 3, we supplemented both BY4742 and reg1 null strains
with 0.34% yeast nitrogen base without amino acids each day, as reg1
null strains are known to be intolerant to nitrogen starvation (Frederick
and Tatchell, 1996). Culture aeration was limited to establish hypoxic
conditions by replacing the typical loose-fitting metal cap of 125 ml
flasks with rubber stoppers and limiting gas exchange to a small-
gauge needle pushed through the stopper.
Oxygen Consumption
Oxygen consumption assays were performed as described in
Bonawitz et al. (2006b).
Mitochondrial Translation Assay
Mitochondrial translation assays were performed essentially as de-
scribed (Rodeheffer and Shadel, 2003). Five milliliter SD cultures
were inoculated to an OD600 of 0.1 and grown 24 hr at 30C, after
which 4 3 108 cells were harvested from each culture. Cells were
incubated with 250 mg/ml of emetine (Sigma) for 5min at 30C to inhibit
cytoplasmic translation. Mitochondrial translation products were la-
beled by incubation with 50 mCi of [35S]methionine for 15 min at
30C, followed by a 10 min chase with 4 ml of chase solution
(15 mM (NH4)2SO4, 1% casamino acids). Cells were washed twice
with 4 ml of chase solution, pelleted and resuspended in 1 ml H2O,ell Metabolism 5, 265–277, April 2007 ª2007 Elsevier Inc. 275
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[35S]methionine incorporation was quantified as counts per minute
by liquid scintillation.
Western Blotting
Cells were grown as described for chronological life-span assays de-
scribed above and harvested at either day 1 (24 hr) or day 2 (48 hr)
postinoculation. Protein (20 mg) was extracted using a standard TCA
precipitation protocol, run on a 12% SDS-PAGE gel, and transferred
to a PVDF membrane (Millipore Immobilon). Both blocking and anti-
body incubations were carried out in TBST (10 mM Tris [pH 8.0],
150 mM NaCl, 0.05% Tween 20) containing 5% nonfat dry milk. Anti-
bodies usedwere actin (Chemicon, 1:1000), Cox2p (Molecular Probes,
1:1000), Cox3p (Molecular Probes, 1:1000), Sod2p (Stressgen, 1:1000),
HRP-conjugated goat a-mouse IgG (Molecular Probes, 1:5000), and
HRP-conjugated donkey a-rabbit IgG (Santa Cruz, 1:5000). Secondary
antibodies were detected with Western Lighting Chemiluminescent
Reagent Plus (PerkinElmer).
Chloramphenicol Resistance Assay
Five milliliter cultures were inoculated to an OD600 of 0.01 in YPG me-
dium containing either 0.25 mg/ml chloramphenicol (Cellgro, Medi-
atech) or an equivalent volume of drug vehicle (ethanol). The OD600
of all cultures was then measured after 24 hr of growth at 30C,
and the number reported is the OD600 ratio for the growth of each strain
in the presence versus absence of chloramphenicol.
Hydrogen Peroxide Sensitivity
Samples (0.5 ml) of a saturated culture at the time point indicated were
added to 0.5 ml of hydrogen peroxide in water at twice the final con-
centration desired and incubated at 30C for 90 min. Cells were then
collected by centrifugation and resuspended in sterile water. Serial di-
lutions were plated onto YPD plates to determine survival. SD cultures
were used in all cases.
Flow Cytometry
Use of dihydroethidium (DHE) to stain for ROS was performed as de-
scribed in Bonawitz et al. (2006b).
Supplemental Data
Supplemental Data include three figures and can be found with this
article online at http://www.cellmetabolism.org/cgi/content/full/5/4/
265/DC1/.
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